<table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="tblu20" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th valign="top">Group 1</th><th valign="top">Group 2</th><th valign="top">Detectable <break/>effect&#160;size <italic>d</italic> <break/>(based on sample size)</th><th valign="top">A priori <break/>power</th><th valign="top">Group 1 <break/>sample size</th><th valign="top">Group 2 <break/>sample size</th></tr></thead><tbody><tr><td valign="top">Drug-na&#239;ve PC9 cells</td><td valign="top">PC9 DTPs</td><td valign="top">3.03763<sup>1</sup></td><td valign="top">80.0%<sup>1</sup></td><td valign="top">4<sup>2</sup></td><td valign="top">4<sup>2</sup></td></tr></tbody></table><table-wrap-foot><fn id="tblfn2"><p><sup>1</sup> A sensitivity calculation was performed since the original data presented in Figures 1E, upper right panel, and Figure 2B were unable to be quantified for all bands. This is the effect size that can be detected with 80% power and the indicated sample size.</p></fn><fn id="tblfn3"><p><sup>2</sup> The sample size is the number of replicates initially performed based on the H3K14Ac analysis.</p></fn></table-wrap-foot></table-wrap>